GlassScriptPhysician profile
George L Murrell
NPI 1427050228
$1,101.80
in general payments reported to CMS, 2019-2025
11 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.67 · 2020: $30.78 · 2021: $108 · 2022: $174 · 2023: $565 · 2024: $92.15 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557 · Travel and Lodging: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.61 |
| Travel and Lodging | $205.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $583.06 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $126.39 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $104.91 | 2021-2023 | Dupixent |
| Glaxosmithkline, LLC. | $89.97 | 2021-2024 | Nucala |
| Medtronic, INC. | $75.21 | 2021-2024 | Sinuva, Propel |
| Braintree Laboratories, INC. | $30.78 | 2020 | |
| Genzyme Corporation | $23.08 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.88 | 2022 | |
| Lundbeck LLC | $18.85 | 2023 | Vyepti |
| Arbor Pharmaceuticals, INC. | $16.06 | 2019 | |
| Integra Lifesciences Corporation | $11.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Murrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.